A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
about
Treating adults with acute lymphocytic leukemia: new pharmacotherapy options.Aurora kinases: novel therapy targets in cancersThe Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid LeukemiaUpdate on emerging treatments for chronic myeloid leukemia.Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase.The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line.An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment.Clinical Development of Anti-mitotic Drugs in Cancer.Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies.RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680).Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia.
P2860
Q30243925-84C3768D-26F5-47AC-AEE1-59190A22A2B5Q33618929-144E9419-FDA5-476E-AD4A-27ED80352B08Q36547224-955BF645-826C-4D72-A06E-EFAD07C06899Q38397515-4A1356E5-E982-48A4-9114-B54CB3736E2DQ38767908-D80F35CF-27A3-4379-80E5-0E2D5807EE4AQ38771103-7182FFB2-F375-4C4E-B06C-91B13419CF32Q38783162-6449173F-DB4D-4E75-B7A0-D16A412BED24Q38829019-490DF2F5-6A3C-4BE3-8321-E4C81948762FQ39363642-E125AA31-D379-4ED5-8156-EFB71A102347Q48218548-CF0B83A1-A6E4-4621-B6E9-B05F4E545A97Q49025576-0FADA28B-BD5F-407C-A54E-581E98C04327Q49887884-33DFD922-45B8-446E-AB18-9770CE41040C
P2860
A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@ast
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@en
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@nl
type
label
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@ast
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@en
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@nl
prefLabel
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@ast
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@en
A phase 2 study of MK-0457 in ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
A phase 2 study of MK-0457 in ...... e acute lymphoblastic leukemia
@en
P2093
A Haregewoin
G Martinelli
P2860
P2888
P356
10.1038/BCJ.2014.60
P577
2014-08-15T00:00:00Z
P5875
P6179
1003024843